218 related articles for article (PubMed ID: 30867321)
1. Preclinical development of an oral anti-
Taylor MJ; von Geldern TW; Ford L; Hübner MP; Marsh K; Johnston KL; Sjoberg HT; Specht S; Pionnier N; Tyrer HE; Clare RH; Cook DAN; Murphy E; Steven A; Archer J; Bloemker D; Lenz F; Koschel M; Ehrens A; Metuge HM; Chunda VC; Ndongmo Chounna PW; Njouendou AJ; Fombad FF; Carr R; Morton HE; Aljayyoussi G; Hoerauf A; Wanji S; Kempf DJ; Turner JD; Ward SA
Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867321
[TBL] [Abstract][Full Text] [Related]
2. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
[TBL] [Abstract][Full Text] [Related]
3. Anti-
Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
[TBL] [Abstract][Full Text] [Related]
4. AWZ1066S, a highly specific anti-
Hong WD; Benayoud F; Nixon GL; Ford L; Johnston KL; Clare RH; Cassidy A; Cook DAN; Siu A; Shiotani M; Webborn PJH; Kavanagh S; Aljayyoussi G; Murphy E; Steven A; Archer J; Struever D; Frohberger SJ; Ehrens A; Hübner MP; Hoerauf A; Roberts AP; Hubbard ATM; Tate EW; Serwa RA; Leung SC; Qie L; Berry NG; Gusovsky F; Hemingway J; Turner JD; Taylor MJ; Ward SA; O'Neill PM
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1414-1419. PubMed ID: 30617067
[TBL] [Abstract][Full Text] [Related]
5. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD
Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621
[TBL] [Abstract][Full Text] [Related]
6. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
von Geldern TW; Morton HE; Clark RF; Brown BS; Johnston KL; Ford L; Specht S; Carr RA; Stolarik DF; Ma J; Rieser MJ; Struever D; Frohberger SJ; Koschel M; Ehrens A; Turner JD; Hübner MP; Hoerauf A; Taylor MJ; Ward SA; Marsh K; Kempf DJ
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007159. PubMed ID: 30818326
[TBL] [Abstract][Full Text] [Related]
7. Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.
Jacobs RT; Lunde CS; Freund YR; Hernandez V; Li X; Xia Y; Carter DS; Berry PW; Halladay J; Rock F; Stefanakis R; Easom E; Plattner JJ; Ford L; Johnston KL; Cook DAN; Clare R; Cassidy A; Myhill L; Tyrer H; Gamble J; Guimaraes AF; Steven A; Lenz F; Ehrens A; Frohberger SJ; Koschel M; Hoerauf A; Hübner MP; McNamara CW; Bakowski MA; Turner JD; Taylor MJ; Ward SA
J Med Chem; 2019 Mar; 62(5):2521-2540. PubMed ID: 30730745
[TBL] [Abstract][Full Text] [Related]
8. Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
Sharma R; Al Jayoussi G; Tyrer HE; Gamble J; Hayward L; Guimaraes AF; Davies J; Waterhouse D; Cook DA; Myhill LJ; Clare RH; Cassidy A; Steven A; Johnston KL; Ford L; Turner JD; Ward SA; Taylor MJ
Sci Rep; 2016 Mar; 6():23458. PubMed ID: 26996237
[TBL] [Abstract][Full Text] [Related]
9. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
[TBL] [Abstract][Full Text] [Related]
10. The Eagle effect in the Wolbachia-worm symbiosis.
Bulman CA; Chappell L; Gunderson E; Vogel I; Beerntsen B; Slatko BE; Sullivan W; Sakanari JA
Parasit Vectors; 2021 Feb; 14(1):118. PubMed ID: 33627171
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.
Clare RH; Cook DA; Johnston KL; Ford L; Ward SA; Taylor MJ
J Biomol Screen; 2015 Jan; 20(1):64-9. PubMed ID: 25278497
[TBL] [Abstract][Full Text] [Related]
12. Anti-Wolbachia drugs for filariasis.
Johnston KL; Hong WD; Turner JD; O'Neill PM; Ward SA; Taylor MJ
Trends Parasitol; 2021 Dec; 37(12):1068-1081. PubMed ID: 34229954
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis.
Ehrens A; Lunde CS; Jacobs RT; Struever D; Koschel M; Frohberger SJ; Lenz F; Fendler M; Turner JD; Ward SA; Taylor MJ; Freund YR; Stefanakis R; Easom E; Li X; Plattner JJ; Hoerauf A; Hübner MP
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007957. PubMed ID: 31986143
[TBL] [Abstract][Full Text] [Related]
14. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA
Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958
[TBL] [Abstract][Full Text] [Related]
15. Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models.
Hübner MP; Gunderson E; Vogel I; Bulman CA; Lim KC; Koschel M; Ehrens A; Frohberger SJ; Fendler M; Tricoche N; Voronin D; Steven A; Chi V; Bakowski MA; Woods AK; Petrassi HM; McNamara CW; Beerntsen B; Chappell L; Sullivan W; Taylor MJ; Turner JD; Hoerauf A; Lustigman S; Sakanari JA
Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():18-27. PubMed ID: 31869759
[TBL] [Abstract][Full Text] [Related]
16. Combinations of the azaquinazoline anti-
Hegde S; Marriott AE; Pionnier N; Steven A; Bulman C; Gunderson E; Vogel I; Koschel M; Ehrens A; Lustigman S; Voronin D; Tricoche N; Hoerauf A; Hübner MP; Sakanari J; Aljayyoussi G; Gusovsky F; Dagley J; Hong DW; O'Neill P; Ward SA; Taylor MJ; Turner JD
Front Microbiol; 2024; 15():1346068. PubMed ID: 38362501
[TBL] [Abstract][Full Text] [Related]
17. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic filariasis and onchocerciasis.
Taylor MJ; Hoerauf A; Bockarie M
Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
[TBL] [Abstract][Full Text] [Related]
19. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro.
Hübner MP; Martin C; Specht S; Koschel M; Dubben B; Frohberger SJ; Ehrens A; Fendler M; Struever D; Mitre E; Vallarino-Lhermitte N; Gokool S; Lustigman S; Schneider M; Townson S; Hoerauf A; Scandale I
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008427. PubMed ID: 32628671
[TBL] [Abstract][Full Text] [Related]
20. Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
Specht S; Pfarr KM; Arriens S; Hübner MP; Klarmann-Schulz U; Koschel M; Sternberg S; Martin C; Ford L; Taylor MJ; Hoerauf A
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006116. PubMed ID: 29300732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
